eHealthMe - FDA and Social Media, Personalized eHealthMe - FDA and Social Media, Personalized

FDA and Social Media, Personalized


Advanced tools       Explore eHealthMe

Home > Orencia > Pamelor > Orencia and Pamelor

Review: Orencia and Pamelor

This review analyzes the effectiveness and drug interactions between Orencia and Pamelor. It is created by eHealthMe based on reports of 17 people who take the same drugs from FDA and social media, and is updated regularly.

Get connected: join a mobile support group for people who take Orencia and Pamelor >>>

What are the drugs

Orencia (latest outcomes from 5,924 users) has active ingredients of abatacept. It is often used in rheumatoid arthritis.

Pamelor (latest outcomes from 2,199 users) has active ingredients of nortriptyline hydrochloride. It is often used in depression.

On Sep, 1, 2014: 17 people who take Orencia, Pamelor are studied

Orencia, Pamelor outcomes

Drug combinations in study:
- Orencia (abatacept)
- Pamelor (nortriptyline hydrochloride)

Drug effectiveness over time :

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ yearsnot specified
Orencia is effectiven/a100.00%
(1 of 1 people)
n/an/an/an/an/an/a
Pamelor is effectiven/an/an/an/a100.00%
(1 of 1 people)
n/an/an/a

Most common drug interactions over time * :

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ yearsnot specified
n/an/an/an/an/an/an/aPneumonia
Systemic Lupus Erythematosus
Asthma
Lower Respiratory Tract Infection
Rash Generalised
Fatigue
Pyrexia
Myelodysplastic Syndrome
Thrombocytopenia
Stress Fracture

Drug effectiveness by gender :

FemaleMale
Orencia is effective100.00%
(1 of 1 people)
n/a
Pamelor is effective100.00%
(1 of 1 people)
n/a

Most common drug interactions by gender * :

FemaleMale
Systemic Lupus ErythematosusMyelodysplastic Syndrome
AsthmaThrombocytopenia
PneumoniaRenal Failure Acute
Lower Respiratory Tract InfectionLiver Injury
FatiguePneumonia
Rash Generalised
Pyrexia
Arthritis
Stress Fracture
Drug Ineffective

Drug effectiveness by age :

0-12-910-1920-2930-3940-4950-5960+
Orencia is effectiven/an/an/an/an/an/a100.00%
(1 of 1 people)
n/a
Pamelor is effectiven/an/an/an/an/an/a100.00%
(1 of 1 people)
n/a

Most common drug interactions by age * :

0-12-910-1920-2930-3940-4950-5960+
n/an/an/an/aLower Respiratory Tract InfectionSystemic Lupus ErythematosusHeadacheMyelodysplastic Syndrome
PneumoniaRash GeneralisedThrombocytopenia
AsthmaPneumoniaArthritis
FatigueRenal Failure AcuteStress Fracture
PyrexiaLiver InjuryDrug Administration Error
PruritusDrug Ineffective
Nausea
Rash

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Orencia and Pamelor?

Get connected! Join a mobile support group:
- group for people who take Orencia and Pamelor
- group for people who take Orencia
- group for people who take Pamelor

Can you answer these questions (what is this?):

More questions for: Orencia, Pamelor

More reviews for: Orencia, Pamelor

Complete drug side effects:

On eHealthMe, Orencia (abatacept) is often used to treat rheumatoid arthritis. Pamelor (nortriptyline hydrochloride) is often used to treat depression. Find out below the conditions the drugs are used for, how effective they are, and any alternative drugs that you can use to treat those same conditions.

What is the drug used for and how effective is it:

Other drugs that are used to treat the same conditions:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

44 million health professionals and patients have studied on eHealthMe. Recent studies:

- Azathioprine for a 39-year old woman who has Ulcerative Colitis (1 hour ago)

- Methamphetamine Hydrochloride for a 33-year old woman who has Low Blood Pressure (1 hour ago)

- Atenolol for a 60-year old man who has High Blood Pressure (2 hours ago)

 

Recent mobile support groups

- Constipation and Pyorrhea - Gum Disease

- Quetiapine Fumarate for Bipolar Ii Disorder

- Hair Loss and Gabapentin

- Shortness Of Breath and Lorazepam

- Vomiting and Fibromyalgia

 

Recent user comments

- "when i use meth i used to have a high blood pressure ... " (1 hour ago)

- "Nerve damage to shoulder. Compressed discs c5 and c7. " (5 hours ago)

- "High Blood pressure Pulmonary Embolism approximately ... " (7 hours ago)

 

Recent searches

- Sudden Memory Loss
- Human Herpesvirus 6 Infection
- Cialis
- Nasal Septum Disorder
- Pancreatic Carcinoma

Recent updates on eHealthMe:

- Allopurinol, Vosol Hc drug interactions (1 second ago)

- Hiv in Morphoea (3 seconds ago)

- Owler, Elixophyllin Sr drug interactions (4 seconds ago)

- Advil Migraine Liqui-gels, Bontril drug interactions (5 seconds ago)

- Amnesia in Lip Oedema (6 seconds ago)

   

About - Terms of service - Privacy policy - Press - Advertise - Apps - Testimonials - Contact us

 
© 2014 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.